0001209191-23-002180.txt : 20230105
0001209191-23-002180.hdr.sgml : 20230105
20230105210737
ACCESSION NUMBER: 0001209191-23-002180
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230103
FILED AS OF DATE: 20230105
DATE AS OF CHANGE: 20230105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gutierrez-Ramos Jose-Carlos
CENTRAL INDEX KEY: 0001667657
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38916
FILM NUMBER: 23513502
MAIL ADDRESS:
STREET 1: C/O MOMENTA PHARMACEUTICALS, INC.
STREET 2: 675 WEST KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER NAME:
FORMER CONFORMED NAME: Guiterrez-Ramos Jose Carlos
DATE OF NAME CHANGE: 20160222
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS plc
CENTRAL INDEX KEY: 0001761612
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: BLOCKS A & B, PORTWAY BUILDING
STREET 2: GRANTA PARK, GREAT ABINGTON
CITY: CAMBRIDGE
STATE: X0
ZIP: CB21 6GS
BUSINESS PHONE: 011441223261503
MAIL ADDRESS:
STREET 1: BLOCKS A & B, PORTWAY BUILDING
STREET 2: GRANTA PARK, GREAT ABINGTON
CITY: CAMBRIDGE
STATE: X0
ZIP: CB21 6GS
FORMER COMPANY:
FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd
DATE OF NAME CHANGE: 20181212
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-03
0
0001761612
BICYCLE THERAPEUTICS plc
BCYC
0001667657
Gutierrez-Ramos Jose-Carlos
C/O BICYCLE THERAPEUTICS PLC
BLOCKS A & B, PORTWAY BUILDING
CAMBRIDGE
X0
CB21 6GS
UNITED KINGDOM
1
0
0
0
Ordinary Shares
2023-01-03
4
A
0
5750
0.00
A
10750
D
Stock Option (right to buy)
29.60
2023-01-03
4
A
0
11500
0.00
A
2033-01-03
Ordinary Shares
11500
11500
D
Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023.
Each RSU represents a contingent right to receive one ordinary share.
This option shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023.
/s/ Lee Kalowski, Attorney-in-Fact
2023-01-05